The case for & against
Bull & Bear analysis
Church & Dwight Co., Inc. (NYSE:CHD) is a prominent player in the consumer packaged goods sector, known for its diversified portfolio of household and personal care products. The company operates a well-rounded suite of established brands, including Arm & Hammer, Trojan, and TheraBreath, with a significant emphasis on innovation and strategic product expansion. Positioned strategically within the value-driven segment of the market, Church & Dwight benefits from strong brand recognition and consistently aims to enhance its operational efficiency amid varying consumer sentiment and broader economic fluctuations.
Bull says
- ↑5% organic sales growth in Q1 surpasses expectations.
- ↑Adjusted EPS $0.95, up 4.4% YoY.
- ↑Gross margin expanded 130bps to 46.4%.
- ↑$300M share repurchase program signals capital confidence.
- ↑International sales up 8.4%, e-commerce 23% of sales.
- ↑New product launches drive ~50% of growth.
Bear says
- ↓2025 organic growth guidance cut to 0–2%.
- ↓Inflation pressures to shrink gross margins by ~60bps.
- ↓Retailer destocking trimmed Q1 sales by ~300bps.
- ↓Underperforming gummy vitamin segment drags overall growth.
- ↓Elevated volatility and weak earnings yield deter risk-averse investors.
- ↓Negative profitability and momentum factors signal performance risks.
Investment themes with CHD
Companies with strong ability to set prices
Earnings Call · Q1 2026 · Mgmt. Guidance
Transcript signals
Bull points
- And so we grew our business around 3%, and we had that 2% help. That's 5% organic. And categories are growing well. We continue to take share. We're getting distribution gains. And that's why we gave an outlook, we think, that's really strong for the full year and really solid for Q3.
- Our portfolio, with its balance of value and premium offerings, continue to perform well in this type of environment, supported by strong brands and innovation.
- Turning to the Q1 results, we delivered a strong start to the year and exceeded our outlook across key metrics. Net sales increased 0.2% ahead of our expectation for a decline. and organic sales grew 5%, well above our 3% outlook. This growth was driven by volume.
Bear points
- the 25 to $30 million headwind that the Middle East conflict has created in terms of higher commodity costs and inflation. We believe we can offset that with productivity. The question that Steve just asked was, well, what happens if that doubles or triples? Can you still just do that with productivity? And the answer was no.
- OxyClean share declined in the quarter as we continue to be impacted by distribution loss and lapping that from a large club retailer a year ago.
- Due to our portfolio actions, our reported sales results would naturally be down 8%.